A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

7.6K views

⸱

DOI:

10.3791/58971

⸱

January 25th, 2019

* These authors contributed equally

In This Article

Summary

Here, we provide a detailed description of an experimental setup for an analysis of the assessment of DNA integrity in stem cells prior to cell transplantation.

Abstract

Stem and stem-cell-derived cells have immense potential as a regenerative therapy for various degenerative diseases. DNA is the storehouse of genetic data in all cells, including stem cells, and its integrity is fundamental to its regenerative ability. Stem cells undergo rapid propagation in labs to achieve the necessary numbers for transplantation. Accelerated cell growth leads to the loss of DNA integrity by accumulated metabolites, such as reactive oxygen, carbonyl, and alkylating agents. Transplanting these cells would result in poor engraftment and regeneration of the deteriorating organ. Moreover, transplanting DNA-damaged cells leads to mutations, DNA instability, cellular senescence, and possibly, life-threatening diseases such as cancer. Therefore, there is an immediate need for a quality control method to evaluate the cell's suitability for transplantation. Here, we provide step-by-step protocols for the assessment of the DNA integrity of stem cells prior to cell transplantation.

Introduction

Experimental and clinical evidence demonstrates that cell transplantation can moderately improve the left ventricle contractile performance of failing hearts1,2,3,4,5,6,7,8,9. Recent advances have opened further appealing opportunities for cardiovascular regeneration; these include the forced expression of reprogramming factors in somatic cells to induce pluripotency an....

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Comet Assay

  1. Reagent preparation
    1. For low-melting-point agarose, place 500 mg of low-melting agarose in 100 mL of DNA-/RNA-free water. Heat the bottle in a microwave oven until the agarose dissolves. Place the bottle in a 37 °C water bath until needed.
      NOTE: For further reading, see Azqueta et al., who studied the effects of agarose concentration on the DNA-unwinding time and several electrophoresis factors23.
    2. Dilute SYBR green DNA dye in Tris-EDTA (TE) Buffer at a 1:10,000 ratio to obtain a 1x working stock dye solution. This dye is light-sensitive, so store it ....

Access restricted. Please log in or start a trial to view this content.

Results

Human induced pluripotent stem cells were cultured, and the DNA damage and the tail moment, which were used as a measure of DNA integrity, were analyzed by comet assay. iPS cells were embedded in low-melting-point agarose and placed on a glass slide. The cells were, then, treated with lysis buffer, followed by an alkaline solution, to obtain supercoiled DNA. Nucleoids were electrophoresed and comets were visualized by DNA dye (Figure 1A-D). T.......

Access restricted. Please log in or start a trial to view this content.

Discussion

DNA integrity portrays cell integrity. Cells with damaged DNA are frequently in stress and eventually lose their integrity. The integrity of stem and stem-cell-derived cells that are being propagated for the purpose of transplantation is principal for the cells to perform their desired function. Transplanting cells with damaged DNA would result in a poor engraftment rate and performance of the cell8,20. Therefore, examining the DNA integrity prior to cell transpl.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

This work was supported in part by National Heart, Lung, and Blood Institute Grants RO1-HL-99507, HL-114120, HL-131017, HL138023, and UO1-HL-134764 (to J. Zhang) and by American Heart Association Scientific Development Grant 17SDG33670677 (to R. Kannappan).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
0.25% TrypsinCorning25200056
8-well chamber slideMillicellPEZGS0816
AccutaseStemcell Technologies7920Cell detachment solution
Alexa Fluor 488 AffiniPure
Donkey Anti-Rabbit IgG
Jackson Immuno
Research Laboratories
711-545-152
(RRID: AB_2313584)
Bovine Serum AlbuminSigma-AldrichA7906
Cy3 AffiniPure Donkey Anti-Rabbit IgGJackson Immuno
Research Laboratories
711-165-152
(RRID:AB_2307443)
DAPISigma-AldrichD9564
Gibco B-27 Supplement, Serum Free,Gibco17504-044
Matrigel growth factor reducedCorning354230
mTeSR1Stemcell Technologies85850
PhalloidinA488Life TechnologyA12379
Phospho-Histone H2A.X (Ser139) AntibodyCell Signaling Technology2577 (RRID: AB_2118010)
RPMIGibco11875-093
SYBR Green I nucleic acid gel stainSigma-AldrichS9430
Triton X-100Fisher scientificBP151-100
UltraPure Low melting Point AgaroseInvitrogen16520050
VectashieldVector LaboratoriesH-1000Antifade

References

  1. Bolli, R., et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. The Lancet. 378 (9806), 1847-1857 (2011).
  2. Makkar, R. R., et al.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Comet AssayGamma-H2AX ImmunolabelingDNA Damage AssessmentiPS-Derived CardiomyocytesCell Transplantation Quality ControlFluorescence MicroscopyCellProfiler AnalysisElectrophoresis ProcedureImmunofluorescence Staining